Navigation Links
BHR Pharma Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial
Date:7/23/2010

>

"This drug has the potential to help a gravely ill population that includes car crash and battlefield injuries and we could not be more pleased to initiate this important trial," said Tom MacAllister, J.D., Ph.D., BHR president and CEO.  "The annual incidence of TBI is higher than breast cancer and HIV/AIDS combined, yet it is largely ignored.  We are proud to lead the efforts to make a difference for these patients and their families."

The leading cause of death and disability in children and young adults worldwide, TBI is involved in nearly half of all trauma deaths.  Traffic accidents account for 40-50 percent of the hospitalizations related to the condition.

BHR was notified in June that the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research had completed its special protocol review and the SyNAPSe trial design and planned analysis adequately address the objectives necessary to support a regulatory submission.  Under the FDA Special Protocol Agreement, BHR will be able to seek marketing approval of BHR-100 without additional pivotal trials, provided the SyNAPSe study results meet specific statistical significance targets and other measures.  The trial is posted on www.clinicaltrials.gov.

Last December, BHR announced that its product had been granted orphan drug status by the FDA Office of Orphan Products Development for early intervention in the treatment of moderate-to-severe closed-head TBI.  The FDA only designates orphan-drug status on novel drugs or biologics that treat a rare disease or condition affecting less than 200,000 A
'/>"/>

SOURCE BHR Pharma, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Health Outcomes Data Essential to Biopharmaceutical Sales Process
2. Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA® Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
3. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
4. Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price
5. Bayer HealthCare Pharmaceuticals Supports New Jersey Governors School in the Sciences at Drew University
6. Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results
7. Lotus Pharmaceuticals Terminates SEDA
8. Patrick J. Zenner Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
9. Huifeng Bio-Pharmaceutical Technology Announces a New Spain Order
10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Flomax®
11. Ampio Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Optina™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... DALLAS , Sept. 15, 2014 /PRNewswire-iReach/ -- ... affects persons of all ages, but most commonly ... condition characterized by narrowing of the airways, leading ... the lungs come into contact with endogenous and ... of events, such as swelling of the airways, ...
(Date:9/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... Valeant Pharmaceuticals International, will redeem all of the outstanding ... Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 (the " ... an irrevocable notice of redemption for the Notes. ... irrevocable notice of redemption with respect to the remaining ...
(Date:9/15/2014)... Sept. 15, 2014  Decision Resources Group,s ... 2014, finds that online information and other ... to differentiate their offering and support physicians. ... purchasing decisions rely on websites, mobile apps ... devices—and these physicians are looking to manufacturers ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3
... , LAWRENCEVILLE, N.J. , Feb. 16 ... announced today that Wayne S. Mulcahy , Ph.D., ... A wholly owned subsidiary of Princeton Pharma Holdings LLC, ... unique products in ophthalmology and orphan diseases. , ...
... , GLEN BURNIE, Md. , Feb. ... delivery provider of prescription medications and veterinary therapeutic and ... Health, opening up the full suite of Pfizer products ... Health is the world,s leader in the discovery, development ...
Cached Medicine Technology:Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2VetCentric Announces Partnership With Pfizer Animal Health 2
(Date:9/15/2014)... “Canada Gynecological Devices Market Outlook ... Canada Gynecological Devices market. The report provides value, ... and average prices (in US dollars) within market ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ... Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), ...
(Date:9/15/2014)... In order to provide predictability and safety, ... to quantify, define and model medical practice. Defined as ... of medical care. , The Journal of BioAcoustic Biology ... the non-profit Institute of BioAcoustic Biology, located in Albany, ... be much more than a measurement tool; math, as ...
(Date:9/15/2014)... Florida is now one of several states holding “no ... test could be forced to undergo a mandatory blood test. ... more people from drinking and driving. , Federal government ... breathalyzer refusal. The new law is aimed to lower this ... , the new Florida law requires people to take a ...
(Date:9/15/2014)... Dennis Thompson HealthDay Reporter ... The severe respiratory virus believed to have sickened hundreds ... now spread to the Northeast, health officials report. ... Friday more than a dozen cases of infection with ... with asthma. And on Saturday, the Connecticut Department ...
(Date:9/15/2014)... 15, 2014 (HealthDay News) -- Births of multiple babies ... death than singleton births, researchers report. The researchers ... vitro fertilization (IVF) could ease some of that burden. ... increased in tandem with births to older mothers and ... the University of New South Wales, Australia. Their ...
Breaking Medicine News(10 mins):Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:New DUI Law Makes Blood Tests Mandatory 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 2Health News:Kids' Severe Respiratory Virus Confirmed in Northeast 3Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3
... California will simultaneously open their doors,Wednesday to Trick or ... SAN DIEGO, Oct. 30 It,s not every ... don,t often,see miniature witches and 3-foot-tall bumblebees, and little ... But at more,than 150 nursing homes in California this ...
... Va.SNM, the worlds largest society for molecular imaging and ... in Tuesdays Roll Call urging Congress to fund basic ... future discoveries. Support DOE funding for nuclear medicine research, ... provides news of legislative and political interest to Capitol ...
... good responses in almost half of patients, study found , ... axitinib shows promise for treating people with what,s known as ... typically have a poor response to drug treatment. , Axitinib ... endothelial growth factor receptors 1, 2 and 3. , ...
... Ohio, Oct. 30 STERIS Corporation,(NYSE: STE ) ... ended September 30, 2007. Fiscal 2008 second quarter revenues,increased ... the second,quarter of fiscal 2007, primarily driven by growth ... quarter net income was $16.0 million, or $0.25 per,diluted ...
... Inc.,(Pink Sheets: HRAL) announced that it has received additional ... International, Inc.,(NYSE: WMT ), to open their ninth ... Wal-Mart Store #3195 located at 1070 Major,Mackenzie Drive in ... #7 Unit Y006A in Markham will both officially open ...
... Oct. 30 Anthera Pharmaceuticals,Inc., a privately held ... diseases, today announced,that Donald J. Santel has been ... experience in transforming early biotech startups into,commercial stage ... our pipeline,and move A-002 into large scale Phase ...
Cached Medicine News:Health News:Halloween Events Bring Young and Old Together for a Ghoulish Good Time 2Health News:SNM ad urges congress to fund nuclear medicine research 2Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 10Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3Health News:Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors 2
... for small and large multi-specialty provider networks. ... check-out. Review the complete Patient History, from ... labs and charts all by one click ... immediately. Communicate electronically with the referring physicians ...
The best value and features offered in a complete EMR and Practice Management Solution...
... Written specifically for urologists by ... utilizes touch screen technology to ... eliminate the use of a ... makes using an EMR faster ...
... The MediNotes Content Department has worked ... comprehensive medical content library and exam templates ... Plus is one of the most flexible ... which will allow you to take the ...
Medicine Products: